Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Eur Rev Med Pharmacol Sci ; 19(16): 3041-5, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26367726

ABSTRACT

Esophageal duplication cysts are a rare medical entity. In most cases they are located at the level of the distal esophagus. Although our case is not unique, we want to focus on it as a reflection on diagnostic methods. The aim of this article is to show through the report on a case of esophageal duplication treated by us, followed by a review of similar cases in the literature, the utility of EUS in the diagnosis of upper-diaphragmatic and not communicating esophageal duplication. We report a case of a 43 year-old woman. She came to our attention for heartburn and retrosternal sense of space. The patient underwent an endoultrasonography (EUS) examination of the esophagus. The framework put EUS diagnosis of cystic formation of the esophagus (esophageal duplication cysts likely). We demonstrate that only EUS has a correlation with the determination of the pre-operative diagnosis with a statistical significance (p <0.001). In the diagnosis of esophageal not communicating duplication cysts EUS is the most specific diagnostic exam.


Subject(s)
Esophageal Cyst/diagnostic imaging , Adult , Esophageal Cyst/pathology , Esophagoscopy/methods , Female , Humans , Treatment Outcome , Ultrasonography
4.
Eur Rev Med Pharmacol Sci ; 14(4): 342-6, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20496545

ABSTRACT

BACKGROUND: Several new biological drugs have been introduced in the last decade or are under investigation for the treatment of IBD. They include anti TNFalpha agents, anti adhesion molecules, anti IL-12/23, anti IL-6R and others. Their role in IBD therapy will be discussed in regard of the association of chronic inflammation and cancer in the gut. The risk of colorectal cancer is increased in ulcerative colitis (UC) and, to some extent, in Crohn's disease (CD). This association is well known from many years. However, the mechanisms linking chronic inflammation and carcinogenesis are beginning to be elucidated only recently. RESULTS AND CONCLUSIONS: Experimental data indicate that several cytokines could play a role in promoting tumour development. In this perspective, the anti cytokine agents could be not only powerful tools in treating inflammation but also efficacious in preventing the onset of inflammation associated colorectal cancer.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/therapeutic use , Inflammatory Bowel Diseases/therapy , Adalimumab , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal, Humanized , Antineoplastic Agents/adverse effects , Certolizumab Pegol , Gastrointestinal Neoplasms/etiology , Humans , Immunoglobulin Fab Fragments/adverse effects , Immunoglobulin Fab Fragments/therapeutic use , Inflammatory Bowel Diseases/complications , Inflammatory Bowel Diseases/pathology , Infliximab , Polyethylene Glycols/adverse effects , Polyethylene Glycols/therapeutic use , Tumor Necrosis Factor-alpha/antagonists & inhibitors
5.
Eur Rev Med Pharmacol Sci ; 12 Suppl 1: 111-7, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18924450

ABSTRACT

Irritable bowel syndrome (IBS) is a complex disorder clinically characterized by abdominal pain and altered bowel habit. Its pathogenetic mechanisms are still incompletely known; genes, psychosocial factors, changes in gastrointestinal motility and visceral hypersensitivity are traditionally thought to play a crucial role in symptom generation. Recent studies have identified new additional factors that can interact with the established mechanisms. Dysregulation of brain-gut axis, gastrointestinal infection, low-grade infiltration and activation of mast cells in the intestinal mucosa with consequent release of bioactive substances, and altered serotonin metabolism are the emerging factors of IBS pathogenesis. Finally, modification of small bowel and colonic microflora and altered gas balance may be of relevance in at least some subgroups of IBS patients. New therapies can be developed only on the basis of a better understanding of the heterogeneous picture of the pathophysiology of IBS.


Subject(s)
Gases/metabolism , Gastrointestinal Motility/physiology , Inflammatory Bowel Diseases/microbiology , Inflammatory Bowel Diseases/physiopathology , Intestines/microbiology , Animals , Gastrointestinal Motility/drug effects , Humans , Inflammatory Bowel Diseases/epidemiology
6.
Endoscopy ; 39(10): 916-9, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17674283

ABSTRACT

We report several cases of hydrogen peroxide-related colitis that occurred in an epidemic pattern in our gastrointestinal endoscopy center during a 2-month period in early 2007. During colonoscopy using sterilized endoscopes that had been flushed with hydrogen peroxide after the peracetic acid cycle, instantaneous effervescence and blanching (the "snow white sign") were observed on the intestinal mucosa when the water button was depressed. Biopsy specimens revealed features resembling a clinical condition which used to be known as "pseudolipomatosis." At follow-up, no patient was found to have suffered morbidity associated with this peroxide colitis. Endoscopists should consider hydrogen peroxide colitis when they see a snow white sign during colonoscopy which cannot be attributed to active inflammation or organic disease of the digestive tract.


Subject(s)
Anti-Infective Agents, Local/adverse effects , Colitis/chemically induced , Colonoscopy/adverse effects , Disease Outbreaks , Hydrogen Peroxide/adverse effects , Colitis/epidemiology , Humans , Iatrogenic Disease/epidemiology , Incidence
7.
Dig Liver Dis ; 39(5): 483-7, 2007 May.
Article in English | MEDLINE | ID: mdl-17379586

ABSTRACT

BACKGROUND: Double-balloon enteroscopy is a newly developed endoscopic method allowing non-surgical full-length exploration of the small bowel, biopsies sample and endoscopic treatment of previously inaccessible lesions. AIM: To prospectively assess the diagnostic and therapeutical impact of double-balloon enteroscopy in patients with suspected or documented small bowel disease. PATIENTS AND METHODS: One hundred consecutive patients referring to our centre for suspected small bowel disease underwent double-balloon enteroscopy. Starting insertion route (anal or oral) of double-balloon enteroscopy was chosen according to the estimated location of the suspected lesions basing on the clinical presentation and on the findings, when available, of previous endoscopic or radiological investigations. Major indications for the procedures were acute recurrent or chronic mid-gastrointestinal bleeding (n=71), suspected gastrointestinal tumours (n=10), suspected Crohn's disease (n=6), chronic abdominal pain and/or chronic diarrhoea (n=8), refractory celiac disease (n=5). RESULTS: One hundred and eighteen double-balloon enteroscopy procedures were carried out. Oral and anal route double-balloon enteroscopies were performed in 54 and 28 patients, respectively, while 18 patients underwent a combination of both approaches. Overall diagnostic yield of double-balloon enteroscopy resulted 69%. Most common pathological findings included angiodysplasias (n=39), ulcerations and erosions of various aetiologies (n=21), tumours (n=7) and ileal stenosis in patients with Crohn's disease suspicion (n=2). In the 65% of the patients examined, double-balloon enteroscopy findings influenced the subsequent clinical management (endoscopic, medical or surgical treatment). No major complications related to the procedure occurred. CONCLUSIONS: Our prospective analysis shows that double-balloon enteroscopy is a useful, safe and well-tolerated new method with a high diagnostic and therapeutic impact for the management of suspected or documented small bowel diseases.


Subject(s)
Endoscopy, Gastrointestinal/methods , Intestinal Diseases/diagnosis , Abdominal Pain/diagnosis , Adolescent , Adult , Aged , Angiodysplasia/diagnosis , Celiac Disease/diagnosis , Chronic Disease , Crohn Disease/diagnosis , Diarrhea/diagnosis , Female , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Neoplasms/diagnosis , Humans , Male , Middle Aged , Prospective Studies
8.
Dig Liver Dis ; 37(12): 952-63, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16214431

ABSTRACT

BACKGROUND: Tissue homeostasis is guaranteed by stem proliferating reserve, depending on dynamic changes in gene expression. A high plasticity is shown by the haematopoietic stem cells, potential source for liver regeneration. AIM: We aimed to evaluate the gene expression modifications induced by human haematopoietic stem cell therapy after liver injury in rats. SUBJECTS: Rats were sorted as follows: (A) human-haematopoietic stem cell injection after allyl alcohol liver damage; (B) only haematopoietic stem cell injection; (C) only allyl alcohol injection; and (D) sacrifice without any treatment. METHODS: Livers, spleens and bone marrows were analysed with flow-cytometry. Livers were also studied by reverse-transcription PCR, histology, immunohistochemistry and microarray analysis; selected genes were confirmed by real-time PCR. RESULTS: In subset A, haematopoietic stem cells were selectively recruited by liver, with respect to the group B, and they improved the liver regeneration process compared to group C. As regards microarrays, haematopoietic stem cell infusion upregulates 265 genes and downregulates 149 genes. Differentially regulated genes belong to a broad range of functional pathways, including proliferation, differentiation, adhesion/migration and transcripts related to oval-cell activation. Real-time PCR validated array results. CONCLUSIONS: Our study confirmed the capacity of haematopoietic stem cells to contribute to liver regeneration. Moreover, microarray analysis led to the identification of genes whose regulation strongly correlates with a more efficient process of liver repair after haematopoietic stem cell injection.


Subject(s)
Chemical and Drug Induced Liver Injury/therapy , Cord Blood Stem Cell Transplantation , Gene Expression , Liver Regeneration , Animals , Chemical and Drug Induced Liver Injury/etiology , Disease Models, Animal , Gene Expression Profiling , Humans , Male , Oligonucleotide Array Sequence Analysis , Rats , Rats, Wistar
9.
J Neurosurg Sci ; 47(3): 167-71; discussion 171, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14618130

ABSTRACT

A case of a 66-year-old woman with anterior-3(rd) falx metastasis from mammary carcinoma is reported. Radiological and therapeutic aspects are reported. The clinical presentation was headache and confusion together with gait disturbance. MRI showed a frontobasal mass with dural attachment suggestive of meningioma. Surgical resection was decided. Histology confirmed the diagnosis of breast cancer dural metastasis. Dural metastases are not frequent. Two radiological aspects are described: subdural hemorrhage and dural mass. No definitive theory exists about etiopathogenesis. As radiological findings are not specific, we emphasize the importance of suspecting dural metastasis in patients with tumor mass involving dura mater.


Subject(s)
Breast Neoplasms/pathology , Dura Mater/pathology , Meningeal Neoplasms/secondary , Meningioma/secondary , Aged , Diagnosis, Differential , Female , Hematoma, Subdural/pathology , Humans , Magnetic Resonance Imaging
12.
Adv Clin Path ; 4(2): 99-106, 2000 Apr.
Article in English | MEDLINE | ID: mdl-11082224

ABSTRACT

Amyloid deposition in secondary amyloidosis frequently involves thyroid gland, but rarely is responsible of a goiter. Amyloid goiter in secondary amyloidosis is characterized by deposition of amyloid A protein (AA) in the gland, associated to atrophic follicles. We identified cases of amyloid goiter in the files of our department in the period from 1985 to 1998. Five cases of amyloid goiter with ingravescent symptomatology, characterized by dyspnea, dysphagia and hoarseness were selected. In four cases of five we observed predisposing conditions as, for example, tuberculosis, Crohn's disease, or rheumatoid arthritis. In all cases the symptoms relative to thyroid enlargement preceded or, anyway, predominated over other clinical evidence of systemic amyloidosis. In one case a symptomatology of systemic amyloidosis was not evident. We would like to underline that in all cases the immunoreactivity for amyloid A in the amorphous material present in the gland permitted the diagnosis of secondary amyloidosis even in the absence of systemic symptoms.


Subject(s)
Amyloidosis/pathology , Goiter/pathology , Adult , Aged , Amyloidosis/complications , Amyloidosis/metabolism , Congo Red , Female , Goiter/complications , Goiter/metabolism , Humans , Immunoenzyme Techniques , Male , Middle Aged , Periodic Acid-Schiff Reaction , Serum Amyloid A Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...